About this trial
Genetics variants could be involved in atypical non-autoimmune diabetes revealed by ketoacidosis. The objective of this research will be to determine the relationships between the genetic variants already described in known monogenic diabetes or identified as involved in glucose metabolism and its regulation, in insulin signaling pathways or in insulin secretion itself in subjects of African and Indian ancestry with atypical forms of non autoimmune diabetes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
subjects of African and Indian ancestry with atypical forms of non autoimmune diabetes.
Trial design
Case-only
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
known pathogenic mutations described in monogenic diabetes of the MODY type
pourcentage
Secondary outcomes
new pathogenic mutations identified in genes involved in glucose metabolism and its regulation,
pourcentage
genetic mutations.
présence/absence
association between clinical and biological data and DNAI
odds ration
comparing the genetic data found in African and Indian ancestry population
Results with a significant p-value (p \< 0.05)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: